Annual CFF
$842.00 K
-$38.00 K-4.32%
December 31, 2023
Summary
- As of February 7, 2025, RPTX annual cash flow from financing activities is $842.00 thousand, with the most recent change of -$38.00 thousand (-4.32%) on December 31, 2023.
- During the last 3 years, RPTX annual CFF has fallen by -$247.00 million (-99.66%).
- RPTX annual CFF is now -99.66% below its all-time high of $247.84 million, reached on December 31, 2020.
Performance
RPTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$166.00 K
+$166.00 K+100.00%
September 30, 2024
Summary
- As of February 7, 2025, RPTX quarterly cash flow from financing activities is $166.00 thousand, with the most recent change of +$166.00 thousand (+100.00%) on September 30, 2024.
- Over the past year, RPTX quarterly CFF has dropped by -$118.00 thousand (-41.55%).
- RPTX quarterly CFF is now -99.93% below its all-time high of $249.03 million, reached on June 30, 2020.
Performance
RPTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$646.00 K
-$118.00 K-15.45%
September 30, 2024
Summary
- As of February 7, 2025, RPTX TTM cash flow from financing activities is $646.00 thousand, with the most recent change of -$118.00 thousand (-15.45%) on September 30, 2024.
- Over the past year, RPTX TTM CFF has dropped by -$256.00 thousand (-28.38%).
- RPTX TTM CFF is now -99.81% below its all-time high of $331.50 million, reached on June 30, 2020.
Performance
RPTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
RPTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.3% | -41.5% | -28.4% |
| 3 y3 years | -99.7% | -54.3% | -49.7% |
| 5 y5 years | +100.0% | -99.8% | -99.4% |
RPTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.1% | at low | -99.8% | -100.0% | -99.3% | at low |
| 5 y | 5-year | -99.7% | at low | -99.9% | +109.8% | -99.8% | +183.5% |
| alltime | all time | -99.7% | -100.0% | -99.9% | +109.8% | -99.8% | +183.5% |
Repare Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $166.00 K(>+9900.0%) | $646.00 K(-15.4%) |
| Jun 2024 | - | $0.00(-100.0%) | $764.00 K(-5.0%) |
| Mar 2024 | - | $375.00 K(+257.1%) | $804.00 K(-4.5%) |
| Dec 2023 | $842.00 K(-4.3%) | $105.00 K(-63.0%) | $842.00 K(-6.7%) |
| Sep 2023 | - | $284.00 K(+610.0%) | $902.00 K(+1.7%) |
| Jun 2023 | - | $40.00 K(-90.3%) | $887.00 K(-15.7%) |
| Mar 2023 | - | $413.00 K(+150.3%) | $1.05 M(+19.5%) |
| Dec 2022 | $880.00 K(-99.1%) | $165.00 K(-38.7%) | $880.00 K(-99.1%) |
| Sep 2022 | - | $269.00 K(+31.2%) | $95.28 M(-0.1%) |
| Jun 2022 | - | $205.00 K(-14.9%) | $95.37 M(-0.3%) |
| Mar 2022 | - | $241.00 K(-99.7%) | $95.61 M(+0.1%) |
| Dec 2021 | $95.56 M | $94.56 M(>+9900.0%) | $95.56 M(+7342.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $363.00 K(-19.2%) | $1.28 M(-265.9%) |
| Jun 2021 | - | $449.00 K(+145.4%) | -$774.00 K(-100.3%) |
| Mar 2021 | - | $183.00 K(-36.7%) | $247.80 M(-0.0%) |
| Dec 2020 | $247.84 M(+140.1%) | $289.00 K(-117.1%) | $247.84 M(+0.1%) |
| Sep 2020 | - | -$1.70 M(-100.7%) | $247.55 M(-25.3%) |
| Jun 2020 | - | $249.03 M(>+9900.0%) | $331.50 M(+302.0%) |
| Mar 2020 | - | $222.00 K(>+9900.0%) | $82.47 M(-20.1%) |
| Dec 2019 | $103.24 M(>+9900.0%) | $0.00(-100.0%) | $103.24 M(0.0%) |
| Sep 2019 | - | $82.25 M(>+9900.0%) | $103.24 M(+391.8%) |
| Jun 2019 | - | $0.00(-100.0%) | $21.00 M(0.0%) |
| Mar 2019 | - | $21.00 M | $21.00 M |
| Dec 2018 | $0.00(-100.0%) | - | - |
| Dec 2017 | $30.46 M | - | - |
FAQ
- What is Repare Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Repare Therapeutics?
- What is Repare Therapeutics annual CFF year-on-year change?
- What is Repare Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Repare Therapeutics?
- What is Repare Therapeutics quarterly CFF year-on-year change?
- What is Repare Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Repare Therapeutics?
- What is Repare Therapeutics TTM CFF year-on-year change?
What is Repare Therapeutics annual cash flow from financing activities?
The current annual CFF of RPTX is $842.00 K
What is the all time high annual CFF for Repare Therapeutics?
Repare Therapeutics all-time high annual cash flow from financing activities is $247.84 M
What is Repare Therapeutics annual CFF year-on-year change?
Over the past year, RPTX annual cash flow from financing activities has changed by -$38.00 K (-4.32%)
What is Repare Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of RPTX is $166.00 K
What is the all time high quarterly CFF for Repare Therapeutics?
Repare Therapeutics all-time high quarterly cash flow from financing activities is $249.03 M
What is Repare Therapeutics quarterly CFF year-on-year change?
Over the past year, RPTX quarterly cash flow from financing activities has changed by -$118.00 K (-41.55%)
What is Repare Therapeutics TTM cash flow from financing activities?
The current TTM CFF of RPTX is $646.00 K
What is the all time high TTM CFF for Repare Therapeutics?
Repare Therapeutics all-time high TTM cash flow from financing activities is $331.50 M
What is Repare Therapeutics TTM CFF year-on-year change?
Over the past year, RPTX TTM cash flow from financing activities has changed by -$256.00 K (-28.38%)